Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma. (25th October 2017) - Lythgoe, Hanna; Baildam, Eileen; Beresford, Michael W; Cleary, Gavin; McCann, Liza J; Pain, Clare E